Trial Profile
A retrospective study of pazopanib in patients with relapsed or refractory soft tissue sarcoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 01 Sep 2015 New trial record